Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03465696 · ClinicalTrials.gov registry record · NA
A Priming Intervention to Increase Patient Willingness to Use Injectables for the Management of Psoriasis
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT03465696 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 180 participants.
The verdict
NCT03465696, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
Biologic medications have revolutionized the treatment of inflammatory diseases such as moderate-to-severe psoriasis. Though very effective with an excellent safety profile, patients may be apprehensive about choosing a biologic medication for a variety of reasons. The purpose of this research study is to learn more about patient's perception of certain psoriasis treatment options.
Interventions
- BEHAVIORAL Group #2 (Intervention)
- BEHAVIORAL Group #3 (Intervention)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2018-05-14 |
| Est. Completion | 2019-06-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03465696
The ClinicalTrials.gov registry entry for NCT03465696 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Group #2 (Intervention) is the first listed.
NCT03465696 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03465696 about?
NCT03465696 is a clinical study titled "A Priming Intervention to Increase Patient Willingness to Use Injectables for the Management of Psoriasis". Biologic medications have revolutionized the treatment of inflammatory diseases such as moderate-to-severe psoriasis. Though very effective with an excellent safety profile, patients may be apprehensive about choosing a biologic medication for a variety of reasons. The purpose of this research study...
What is the current status of trial NCT03465696?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2018-05-14. Estimated completion is 2019-06-21.
What interventions are being tested in trial NCT03465696?
The interventions under investigation include: Group #2 (Intervention) (BEHAVIORAL), Group #3 (Intervention) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03465696?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.